Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 28, 2017

DrugPatentWatch Database Preview


« Back to Dashboard

Which patents cover Rosuvastatin Calcium, and what generic alternatives are available?

Rosuvastatin Calcium is a drug marketed by Changzhou Pharm, Hetero Labs Ltd V, Torrent Pharms Llc, Accord Hlthcare, Apotex Inc, Biocon Ltd, Cadila Pharms Ltd, Mylan Pharms Inc, Jubilant Generics, Alkem Labs Ltd, Teva Pharms Usa, Watson Labs Inc, Par Pharm Inc, Sun Pharma Global, Aurobindo Pharma Ltd, Sandoz Inc, and Glenmark Pharms. and is included in seventeen NDAs.

The generic ingredient in ROSUVASTATIN CALCIUM is rosuvastatin calcium. There are thirty-eight drug master file entries for this compound. Forty-one suppliers are listed for this compound. There are three tentative approvals for this compound. Additional details are available on the rosuvastatin calcium profile page.

Summary for Tradename: ROSUVASTATIN CALCIUM

Suppliers / Packagers: see list28
Bulk Api Vendors: see list67
Clinical Trials: see list904
Patent Applications: see list113
Formulation / Manufacturing:see details
Drug Prices:see details

Pharmacology for Tradename: ROSUVASTATIN CALCIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Pharms Usa
rosuvastatin calcium
TABLET;ORAL079166-001Jul 19, 2016ABRXNoNo► Subscribe► Subscribe
Mylan Pharms Inc
rosuvastatin calcium
TABLET;ORAL079161-004Jul 19, 2016ABRXNoNo► Subscribe► Subscribe
Par Pharm Inc
rosuvastatin calcium
TABLET;ORAL079168-001Jul 19, 2016ABRXNoNo► Subscribe► Subscribe
Aurobindo Pharma Ltd
rosuvastatin calcium
TABLET;ORAL079170-004Jul 19, 2016ABRXNoNo► Subscribe► Subscribe
Watson Labs Inc
rosuvastatin calcium
TABLET;ORAL079167-001Apr 29, 2016ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Find generic sources and suppliers
  • Uncover prior art in abandoned patent applications and expired patents
  • Obtain formulation and manufacturing information

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus